NSPR (InspireMD) Short Interest


NSPR InspireMD Inc NSPR
35 GF Score
Price $0.70
GF Value $1.78
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is InspireMD Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NSPR vs TELA, MYO, PAVM: Short Interest Comparison

For the Medical Devices subindustry, InspireMD's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InspireMD Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InspireMD's Short Interest distribution charts can be found below:

* The bar in red indicates where InspireMD's Short Interest falls into.


NSPR
35GF Score
InspireMD Inc NSPR
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is InspireMD (NSPR) Overvalued in 2026?

Based on GuruFocus' analysis, InspireMD stock appears to be undervalued. The current stock price of $0.70 is trading 60.7% below its estimated GF Value™ of $1.78. GuruFocus considers InspireMD to be Possible Value Trap.

Key valuation signals for NSPR:

  • Short Interest:
  • GF Value™: $1.78 vs. price of $0.70 (60.7% below fair value)
  • GF Score™: 35/100 with 3 warning signs

No single metric tells the full story. See the NSPR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

InspireMD Business Description

Other Exchanges II2:Germany
Address 6303 Waterford District Drive, Suite 215, Miami, FL, USA, 33126
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
35GF Score

Get the complete analysis for NSPR

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.70
Price
$1.78
GF Value